Compare ADMA Biologics Inc (ADMA) vs Aehr Test Systems (AEHR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ADMA Biologics Inc vs Aehr Test Systems — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while Aehr Test Systems trades at $119.98 (market cap $3.82B). The key difference: Aehr Test Systems is the larger of the two by market cap, and Aehr Test Systems is trading nearer its 52-week high, ADMA Biologics Inc nearer its low. Which is the better fit depends on your goals.
| ADMA | AEHR | |
|---|---|---|
Market Cap | $2.22B | $3.82B |
Sector | Health | Technology |
52-Week High | $20.38 | $117.18 |
52-Week Low | $7.60 | $17.38 |
Enterprise Value | $2.29B | $3.72B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About Aehr Test Systems
Aehr Test Systems provides testing and burn-in solutions for the semiconductor industry. Its systems ensure the reliability of AI processors, data center chips, and electric vehicle components at the wafer and package levels.
Read more on AEHR →
